Middle East Neurology Devices Market Analysis Report 2022 to 2030

Middle East Neurology Devices Market Analysis

$ 3999

The Middle East Neurology Devices Market size was valued at $505 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.8% from 2022 to 2030 and will reach $991 Mn in 2030. The Middle East neurology devices market is expanding as a result of increased rates of neurovascular illnesses, a rising desire for less invasive procedures, and a progressively ageing population. The demand for neurology devices in the Middle East is being driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, and Parkinson's disease. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, Microport Scientific, Nihon Kohden, and Midikit.

ID: IN10MEMD012 CATEGORY: Medical Devices GEOGRAPHY: Middle East AUTHOR: Jigyasu Bhandari

Buy Now

Middle East Neurology Devices Market Executive Analysis

The Middle East Neurology Devices Market is at around $505 Mn in 2022 and is projected to reach $991 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. Healthcare expenditures in Qatar were among the highest in the Middle East in 2014, at $4.7 billion. In 2018, Israel's national healthcare spending increased by 4.3%, totalling $28.54 Bn per citizen. In terms of a percentage of Israel's GDP, health spending made up 7.6%.In 2017, the expected total health spending was $3.17 billion, or 8.6% of the GDP. The cost of providing for public health as a share of GDP is 5.5%. The entire cost of pharmaceuticals makes up about 25.9% of all health spending and contributes to 2.88% of the GDP.

In the Middle East neurological disorders are among the most prevalent and have a serious detrimental impact on patients, their families, and society, which is becoming increasingly widely understood. Therefore, neurological diseases contribute significantly to morbidity and mortality in the area. For patients diagnosed in operating rooms and intensive care units, specialised monitoring is essential in order to reduce ischemia and mechanical harm to the nervous system. Due to the loss of dopaminergic neurons in the substantial nigra, Parkinson's Disease (PD), the second most common neurodegenerative condition, is characterised by decreasing levels of dopamine. Tremors, dyskinesia, and rigidity are common parkinsonian motor symptoms at the beginning of the disease, but other non-motor symptoms emerge as the condition worsens, such as constipation, anosmia, and cognitive failure. Through mechanisms like a mitochondrial failure, oxidative stress, and neuroinflammation, exposure to methamphetamines, dairy products, pesticides, or comorbidities (such as cancer and traumatic brain damage) predispose people to develop Parkinson's disease. Depending on the Parkinson’s disease subtype, the prognosis varies, but in general, a diagnosis is followed by a life expectancy of 7 to 14 years.

Middle East Neurology Device Market Analysis

Market Dynamics

Market Growth Drivers

The Middle East neurology devices market is expanding as a result of increased rates of neurovascular illnesses, a rising desire for less invasive procedures, and a progressively ageing population. The demand for neurology devices in the Middle East is being driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, and Parkinson's disease. Demand in the Middle East is being driven by the creation of modern neurology devices with greater precision, effectiveness, and safety. To enhance healthcare services and outcomes, Middle Eastern governments are increasingly putting money into the infrastructure of the medical field, which includes neurology devices.

Market Restraints

The Middle East neurology devices market is anticipated to grow more slowly due to elements including the high price of embolization coils. The lack of a strong healthcare infrastructure in some Middle Eastern areas can restrict access to neurology equipment and other medical treatments.

Competitive Landscape

Key Players

Microport Scientific
Medtronic
Johnson and Johnson
Penumbra
Nihon Kohden
Medikit

Notable Deals

2021: The Saudi Food and Drug Authority granted Abbott Laboratories Infinity Deep Brain Stimulation (DBS) system official certification in 2021. The technology is intended to treat essential tremors and Parkinson's disease.

2021: The acquisition of Neural Diagnostics by Nihon Kohden Corporation, a Japanese medical device business. Neural Diagnostics is a UAE-based medical device firm that creates and produces non-invasive neurodiagnostic equipment. The acquisition, which was disclosed in 2021, is a component of Nihon Kohden's plan to grow its international clientele and fortify its line of neurology devices.

Healthcare Policies and Regulatory Landscape

Middle East healthcare policies and the regulatory landscape for neurology devices are tightening and aligning with worldwide norms, which are fueling the expansion of the market for neurology devices there. Each Middle Eastern nation's Ministry of Health (MoH) is responsible for policing healthcare practices, including the use of neurology devices. A uniform regulatory framework for neurological devices has been developed by the Gulf Cooperation Council (GCC), a regional association of six Middle Eastern nations. To assure the safety, effectiveness, and quality of medical devices in Saudi Arabia, particularly neurology devices, the Saudi Food and Drug Authority (SFDA) regulates their use. Federal Health Authority (FHA) of the United Arab Emirates (UAE) oversees the regulation of medical equipment in the UAE, particularly neurological devices, and guarantees that they adhere to international standards.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.